These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28633956)

  • 1. A time-adjustable pulsatile release system for ketoprofen: In vitro and in vivo investigation in a pharmacokinetic study and an IVIVC evaluation.
    Wang H; Cheng L; Wen H; Li C; Li Y; Zhang X; Wang Y; Wang Y; Wang T; Pan W; Yang X
    Eur J Pharm Biopharm; 2017 Oct; 119():192-200. PubMed ID: 28633956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Three-Pulse Release Tablet for Amoxicillin: Preparation, Pharmacokinetic Study and Physiologically Based Pharmacokinetic Modeling.
    Li J; Chai H; Li Y; Chai X; Zhao Y; Zhao Y; Tao T; Xiang X
    PLoS One; 2016; 11(8):e0160260. PubMed ID: 27479702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of ketoprofen bioavailability by formation of microsponge tablets.
    Comoglu T; Savaşer A; Ozkan Y; Gönül N; Baykara T
    Pharmazie; 2007 Jan; 62(1):51-4. PubMed ID: 17294814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel extended IVIVC combined with DoE to predict pharmacokinetics from formulation compositions.
    Lim JY; Kim TH; Song CH; Kim DH; Shin BS; Shin S
    J Control Release; 2022 Mar; 343():443-456. PubMed ID: 35124130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a Time-Controlled Pulsatile Release System for Propranolol Using the Dry-Coated Method: In Vitro and In Vivo Evaluation.
    Chen K; Wang Y; Gai X; Wang H; Li Y; Wen H; Pan W; Yang X
    AAPS PharmSciTech; 2017 Oct; 18(7):2683-2690. PubMed ID: 28281210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and in vitro/in vivo evaluation of a ketoprofen orally disintegrating/sustained release tablet.
    Wei Q; Yang F; Luan L
    Drug Dev Ind Pharm; 2013 Jun; 39(6):928-34. PubMed ID: 22401710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects.
    Lorier M; Magallanes L; Ibarra M; Guevara N; Vázquez M; Fagiolino P
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):787-793. PubMed ID: 26590950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined site-specific release retardant mini-matrix tablets (C-SSRRMT) for extended oral delivery of dexketoprofen trometamol:
    Sweed NM; Basalious EB; Nour SA
    Drug Dev Ind Pharm; 2019 Nov; 45(11):1777-1787. PubMed ID: 31418598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an Extended-Release Formulation for Apremilast and a Level A in Vitro-in Vivo Correlation Study in Beagle Dogs.
    Tang M; Hu P; Huang S; Zheng Q; Yu H; He Y
    Chem Pharm Bull (Tokyo); 2016 Nov; 64(11):1607-1615. PubMed ID: 27568485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and pharmacokinetics study on gastro-floating sustained-release tablets of troxipide.
    Gao Y; Gao Y; Yin F; Wang M; Wang Z; Ye T; Yang Y; Pan WS; Yang X
    Drug Dev Ind Pharm; 2015; 41(9):1443-51. PubMed ID: 25190152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and uniform evaluation of ropinirole osmotic pump tablets with REQUIP XL both in vitro and in beagle dogs.
    Li Z; Yu F; Di Z; Zhao X; Zhao S; Liu Y; Li Y; Wang Z; Gong W; Zhang H; Yang Y; Xie X; Mei X
    Drug Dev Ind Pharm; 2016 Jan; 42(1):12-18. PubMed ID: 25830369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
    Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ
    Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of the method and timing of administration on the systemic transport of ketoprofen].
    Delhotal Landes B; Decout N; Molinier P; Flouvat B
    Pathol Biol (Paris); 1998 May; 46(5):355-9. PubMed ID: 9769898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro/in-vivo correlation of pulsatile drug release from press-coated tablet formulations: a pharmacoscintigraphic study in the beagle dog.
    Ghimire M; McInnes FJ; Watson DG; Mullen AB; Stevens HN
    Eur J Pharm Biopharm; 2007 Sep; 67(2):515-23. PubMed ID: 17498934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
    Hosny EA; el-Mahrouk GM; Gouda MW
    Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluations of ketoprofen extended release pellets prepared using powder layering technique in a rotary centrifugal granulator.
    Pai R; Kohli K; Jain G; Srivastava B
    Arch Pharm Res; 2011 Jul; 34(7):1135-42. PubMed ID: 21811920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of a time-specific pulsatile-release tablet of aceclofenac: a solution for morning pain in rheumatoid arthritis.
    Qureshi J; Ahuja A; Baboota S; Chutani K; Jain S; Ali J
    Methods Find Exp Clin Pharmacol; 2009; 31(1):15-23. PubMed ID: 19357794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new approach for preparing a controlled release ketoprofen tablets by using beeswax.
    Uner M; Gönüllü U; Yener G; Altinkurt T
    Farmaco; 2005 Jan; 60(1):27-31. PubMed ID: 15652365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimetazidine Dihydrochloride Pulsatile-Release Tablets for the Treatment of Morning Anginal Symptoms: Dual Optimization, Characterization and Pharmacokinetic Evaluation.
    Othman AI; Amin MM; Abu-Elyazid SK; Abdelbary GA
    Curr Drug Deliv; 2021; 18(8):1182-1196. PubMed ID: 33583377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.